Exagen inc. reports strong first quarter 2024 results: raises guidance for full year

Carlsbad, calif., may 13, 2024 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended march 31, 2024.

XGN Ratings Summary

XGN Quant Ranking